Postoperative Hyperuricemia-A Risk Factor in Elective Cardiosurgical Patients

Area of Science:

• Cardiology
• Critical Care Medicine
• Nephrology

Background:

• Hyperuricemia is an established cardiovascular risk factor.
• The impact of postoperative hyperuricemia on cardiac surgery outcomes requires further investigation.

Purpose of the Study:

• To assess the association between postoperative hyperuricemia and adverse outcomes in patients undergoing elective cardiac surgery.
• To compare the incidence of prolonged mechanical ventilation, intensive care unit (ICU) stay, and postoperative complications between patients with and without postoperative hyperuricemia.

Main Methods:

• Retrospective analysis of 227 patients after elective cardiac surgery.
• Patients were categorized into two groups: those with postoperative hyperuricemia (n=42) and those without (n=185).
• Primary outcomes included duration of mechanical ventilation and ICU stay; secondary outcomes comprised postoperative complications and mortality.

Main Results:

• Patients with postoperative hyperuricemia experienced significantly longer ICU treatment durations (p=0.03) and mechanical ventilation (p<0.01).
• Higher incidences of circulatory instability/low cardiac output syndrome (p<0.01), renal failure/continuous venovenous hemodiafiltration (p<0.001), and mortality (p<0.01) were observed in the hyperuricemia group.
• Preoperative characteristics, EuroSCORE, and comorbidities like hypertension were similar between groups.

Conclusions:

• Postoperative hyperuricemia is associated with poorer outcomes following elective cardiac surgery.
• Elevated uric acid levels post-cardiac surgery indicate an increased risk of prolonged recovery, critical complications, and mortality.
• Monitoring and managing hyperuricemia may be crucial for improving patient outcomes after cardiac surgery.